bcbs fep glp 1 coverage 2025 glp-1 GLP-1 Drugs: 2025 Pulse Survey (U.S.) Who Gets the Shot? GLP-1

21K07377), Keio University Global Research Institute Pre-Start-up Grant 2022, and research grants from Daiwa Securities Health Foundation, Takeda Science Foundation, and the 2021 Inamori Research Grant Program

It was the first hormone-mimicking drug to be approved to treat type 2 diabetes

Infographic Summary Comparing US and UK Diabetes Treatment Guidelines: 1

The medication should typically be just one part of an individuals weight-management plan

If approved, we believe pemvidutide could offer an important option for obesity patients, including those with risk factors for cardiovascular disease. However, tolerability issues remain, as the trial led to one participant experiencing vomiting, and 4.1% of the patients in the drug cohort discontinuing treatment in the first 16 weeks, when compared to 2.1% in the placebo group